Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease

Keyphrases

• Myofibroblast 100%
• Matrix Producing 100%
• Fibrotic Diseases 100%
• Origin Activation 100%
• Pericytes 66%
• Signaling Pathway 33%
• Fibrosis 33%
• Antifibrotic 33%
• Patient Demographics 33%
• Cellular Mechanisms 33%
• Progenitor Cells 33%
• Mesenchymal Cells 33%
• Major Pathway 33%
• Targeted Therapeutics 33%
• Solid Organ 33%
• Perivascular Fibroblasts 33%
• Scar Formation 33%
• Transdifferentiation 33%
• Myofibroblast Differentiation 33%
• Myofibroblast Proliferation 33%
• Organ Fibrosis 33%
• Chronic Progressive 33%
• Growing Patients 33%
• Fibrosis Formation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Fibrosis 100%
• Diseases 100%
• Scar Formation 33%

Immunology and Microbiology

• Myofibroblast 100%
• Pericyte 40%
• Fibroblast 40%
• Cell Transdifferentiation 20%
• Scar Formation 20%